Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk

Urology
De-Ke JiangLong Yu

Abstract

To perform a meta-analysis to explore a more robust estimate of the effect of the TP53 Arg72Pro polymorphism on bladder cancer risk. Studies investigating the association between TP53 Arg72Pro polymorphism and bladder cancer risk have reported conflicting results. All eligible studies were searched in PubMed. The quality of the studies was evaluated according to a predefined scale. Crude odds ratios, with the 95% confidence intervals, were assessed for the association using fixed- and random-effects models. We identified 10 case-control studies involving 3549 subjects for the present meta-analysis. Overall, no evidence of an association was observed between the TP53 genotypes and bladder cancer susceptibility when all the studies were pooled into the meta-analysis. However, a significantly decreased risk of bladder cancer was associated with TP53 genotypes for Arg/Arg versus Pro/Pro (odds ratio 0.74, 95% confidence interval 0.55-0.99) and Arg/Arg plus Arg/Pro versus Pro/Pro (odds ratio 0.77, 95% confidence interval 0.59-1.00) in Asians. In contrast, no effect of this polymorphism on bladder cancer in whites, Africans, or other population was observed when only high-quality scored studies were considered. The results of the pres...Continue Reading

References

Feb 1, 1987·Molecular and Cellular Biology·G J MatlashewskiL V Crawford
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Aug 1, 1995·Japanese Journal of Cancer Research : Gann·W J WuO Yoshida
Jul 15, 1995·Lancet·J M LancasterJ Taylor
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Jan 10, 2002·Fertility and Sterility·Chi Chen ChangCheng Chieh Lin
Mar 13, 2002·Cancer Letters·Nikolaos SoulitzisDemetrios A Spandidos
Nov 26, 2002·Cancer Letters·Yoshiki KurodaTakahiko Katoh
Feb 5, 2003·Nature Genetics·Patrick DumontMaureen Murphy
Feb 15, 2003·American Journal of Human Genetics·Adele A MitchellAravinda Chakravarti
Feb 12, 2004·European Journal of Human Genetics : EJHG·Louise HoskingChun-Fang Xu
Mar 18, 2004·Journal of the National Cancer Institute·Sholom WacholderNathaniel Rothman
Mar 23, 2004·Annals of the New York Academy of Sciences·Imed MabroukAli Gargouri
Apr 2, 2004·Cell·Arnold J LevinePhilip W Hinds
Mar 15, 2005·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Y-C ChenD C Christiani
Apr 14, 2005·European Journal of Human Genetics : EJHG·Georgia SalantiJohn P A Ioannidis
Jun 5, 2007·International Journal of Cancer. Journal International Du Cancer·Yong ZhouXiao-Ting Wu
Jul 22, 2008·Toxicology and Applied Pharmacology·Chi-Jung ChungYu-Mei Hsueh
Jan 24, 2009·Nature Reviews. Cancer·Catherine WhibleyMonica Hollstein
Apr 22, 2009·Journal of Cellular and Molecular Medicine·Roman HrstkaBorivoj Vojtesek
Jul 23, 2009·International Journal of Cancer. Journal International Du Cancer·Lili YanBaohui Han
Jul 25, 2009·Breast Cancer Research and Treatment·Zhizhong ZhangZhengdong Zhang
Aug 21, 2009·European Urology·Lin T GueyUNKNOWN EPICURO/Spanish Bladder Cancer Study investigators
Jan 7, 2010·Toxicology Letters·Dimitrios VolanisVassilis Zoumpourlis

❮ Previous
Next ❯

Citations

Dec 28, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yan ZhangShengkai Gong
Nov 13, 2012·Molecular Biology Reports·Chuan LiuYajie Wang
Jan 1, 2011·Journal of Biomedical Research·Lifeng ZhangNinghan Feng
Sep 18, 2014·The Journal of Obstetrics and Gynaecology Research·Jing LiaoDing Ma
Jul 18, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Zhen YangChun-Lin Zhao
Jun 19, 2014·Molecular and Clinical Oncology·Yanfeng YangJinxing Wei
Oct 24, 2019·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Zhen Cheng, Zhiwei Liu
Jun 19, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Junjie WuJiu-Cun Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis